Trabectedin: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Trabectedin. Educational only — not medical advice.

Labeled uses

EVDI is indicated for the treatment of adult patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen [see Clinical Studies (14) ] .

Source: FDA labeling via NIH DailyMed (set c1d50f5c…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.